𝔖 Bobbio Scriptorium
✦   LIBER   ✦

IGF-2 autocrine stimulation in tumorigenic clones of a human colon-carcinoma cell line

✍ Scribed by Thomas Lamonerie; Christian Lavialle; Hedi Haddada; Olivier Brison

Publisher
John Wiley and Sons
Year
1995
Tongue
French
Weight
716 KB
Volume
61
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Clonal analysis has shown that the SW613‐S human colon‐carcinoma cell line is heterogeneous; some cell clones display a high level of amplification of the c‐myc gene and are tumorigenic in nude mice, whereas others have a small number of copies of this gene and are non‐tumorigenic. Tumorigenic clones can proliferate in a chemically defined serum‐free medium, whereas non‐tumorigenic clones cannot. Suramin, like anti‐insulin‐like growth factor (IGF) or anti‐IGF‐1 receptor antibodies, efficiently inhibits the growth of tumorigenic clones in defined medium. Inhibition by suramin or by anti‐IGF antibodies can be reversed by pure IGF‐1 or IGF‐2. Pure IGF‐1 or IGF‐2 or culture medium conditioned by tumorigenic clones can stimulate DNA synthesis in cells of non‐tumorigenic clones. Co‐culture with cells of tumorigenic clones sustains the growth of non‐tumorigenic clones in defined medium. Cells of both tumorigenic and non‐tumorigenic clones express high‐affinity IGF‐1 receptors at their surface but tumorigenic clones produce on average 5 times more IGF‐1 and 25 times more IGF‐2 than non‐tumorigenic ones. These results indicate that autocrine growth stimulation of tumorigenic clones by IGFs through the IGF‐I receptor is essential for their ability to grow in defined medium. Since cells of tumorigenic clones produce IGF‐2 at levels 80 times higher than IGF‐1 and since an antibody strictly specific for IGF‐1 has no effect on DNA synthesis in cells of tumorigenic clones grown in defined medium, IGF‐2 is very likely the main effector in the autocrine loop. © 1995 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

2′-Deoxyadenosine causes apoptotic cell
2′-Deoxyadenosine causes apoptotic cell death in a human colon carcinoma cell line
✍ Michela Giannecchini; Barbara D'Innocenzo; Rossana Pesi; Francesco Sgarrella; Ma 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views

## Abstract The combination of 2′‐deoxyadenosine and 2′‐deoxycoformycin is toxic for the human colon carcinoma cell line LoVo. In this study we investigated the mode of action of the two compounds and have found that they promote apoptosis. The examination by fluorescence microscopy of the cells tr

Quantification of protein transcytosis i
Quantification of protein transcytosis in the human colon carcinoma cell line CaCo-2
✍ Martine Heyman; Anne-Marie Crain-Denoyelle; Samir Kumar Nath; Jehan-Francois Des 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

The transepithelial absorption of food-type proteins has been shown to proceed by endocytosis along two functional pathways: a minor direct pathway allowing transport of intact protein and J major lysosomal degradative pathway. The human colon carcinoma cell line CaCo-2 grown on Millipore filters wa

Evidence for autocrine activation of a t
Evidence for autocrine activation of a tyrosine kinase in a human gastric carcinoma cell line
✍ Silvia Giordano; Maria Flavia Di Renzo; Radha P. Narsimhan; Luca Tamagnone; Elen 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB

Phosphotyrosine (P-Tyr) antibodies have been used to identify the phosphorylated forms of growth factor receptors and oncogene-coded tyrosine kinases. Western blot analysis of a gastric carcinoma cell line with P-Tyr antibodies revealed a tyrosine-phosphorylated protein of M, 145,000 (P145). In addi

Surface-bound plasmin induces selective
Surface-bound plasmin induces selective proteolysis of insulin-like-growth-factor (IGF)-binding protein-4 (IGFBP-4) and promotes autocrine IGF-II bio-availability in human colon-carcinoma cells
✍ Maryse M. Remacle-Bonnet; Françoise L. Garrouste; Gilbert J. Pommier 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 162 KB 👁 2 views

Limited proteolysis of insulin-like-growth-factor (IGF)-binding proteins (IGFBPs) represents a key process to modulate IGF bio-availability at the cellular level. In human colon carcinomas, urokinase-type plasminogen activator (u-PA) produced by stroma cells can bind to cancer-cell-associated u-PA r